Trials / Completed
CompletedNCT02609087
Effect on Cerebral Oxygenation by Sevoflurane or Propofol Using Near-infrared Spectroscopy in Carotid Endarterectomy
Comparison the Effect on Cerebral Oxygenation by Sevoflurane-remifentanil or Propofol-remifentanil Anesthesia Using Near-infrared Spectroscopy in Patients Undergoing Carotid Endarterectomy)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Chonnam National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is comparing the effect on cerebral oxygenation by sevoflurane-remifentanil or propofol-remifentanil anesthesia in patient undergoing carotid endarterectomy. Cerebral oxygenation is measured by near-infrared spectroscopy. Sevoflurane and propofol reduce the cerebral metabolic rate for oxygen in similar degree. Propofol decrease the cerebral blood flow by dose-dependent manner, however, sevoflurane increase the cerebral blood flow in the concentration of avobe 1 MAC. Both drugs are widely used in general anesthesia for neurosurgical procedure, and their effect on cerebral oxygenation are acceptable. There is little data about the effect of general anethetics on cerebral oxygenation in patients undergoing carotid endarterectomy, who have imparied cerebral circulation. Our hypothesis is sevoflurane will show better cerebral oxygenation than propofol in patient have impaired cerebral circulation.
Detailed description
This study is performed by monitoring the cerebral oxygenation using near-infrared spectroscopy from general anesthesia induction to 10 min after releasing the carotid artery clipping. Study group: Sevoflurane - remifentanil anesthesia group (S) Propofol - remifentanil anesthesia group (R) Monitoring: near-infrared spectroscopy (SOMA sensor) BIS, HR, arterial blood pressure, SpO2, body temperature Patient seletion * inclusion criteria * American Society of Anesthesiologist (ASA) physical status 1-3 * 18 \~ 70 years * patient who agree with informed concent * exclusion criteria * ASA physical status \> 4 * preoperative SpO2 \< 97% * patient who has other neurologic disease not related to carotid endarterectomy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sevoflurane | |
| DRUG | Propofol |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2015-11-20
- Last updated
- 2017-01-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02609087. Inclusion in this directory is not an endorsement.